SYNTAXIN LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United Kingdom	36
#2	United States	27
#3	WIPO (World Intellectual Property Organization)	16
#4	China	14
#5	Canada	10
#6	EPO (European Patent Office)	8
#7	Republic of Korea	7
#8	Japan	6
#9	Australia	4
#10	Brazil	4
#11	South Africa	4
#12	Argentina	3
#13	Hong Kong	3
#14	Israel	3
#15	India	3
#16	Mexico	2
#17	Singapore	2
#18	Ukraine	2
#19	Norway	1
#20	Taiwan	1

#	Technology
#1	Medical preparations
#2	Therapeutic chemical compounds
#3	Peptides
#4	Microorganisms
#5	Enzymes
#6	Climate change adaptation technologies
#7	Analysing materials
#8	Fermentation
#9	Measuring microorganism processes
#10	Specific use of cosmetics

Publication	Filing date	Title
GB201407525D0	2014-04-29	Manufacture of recombinant clostridium botulinum neurotoxins
US2014302006A1	2014-04-11	Suppression of neuroendocrine diseases
GB201322766D0	2013-12-20	Delivery vehicle
GB201312317D0	2013-07-09	Cationic neurotoxins
GB201312295D0	2013-07-09	Suppression of itch
GB201303108D0	2013-02-21	Therapeutics for suppressing osteoporosis
GB201300118D0	2013-01-04	Delivery vehicle
CA2880897A1	2012-11-21	Methods for the manufacture of proteolytically processed polypeptides
GB201219602D0	2012-10-31	Recombinant clostridium botulinum neurotoxins
GB201219024D0	2012-10-23	Assay
BR132012005613E2	2012-03-13	Simple chain polypeptide fusion protein and method for preparation, polynucleotidic molecule, expression vector, method for preparing a non-cytotoxic agent, non cypotypeane polypeptide use
GB201200096D0	2012-01-05	Delivery vehicle
ZA201104679B	2011-06-23	Suppression of cancers
AU2011203062A1	2011-06-23	Suppression of cancers
ZA201104656B	2011-06-23	Suppression of neuroendocrine diseases
AU2011203060A1	2011-06-23	Suppression of neuroendocrine diseases
GB201108108D0	2011-05-16	Therapeutic fusion proteins
US2011152174A1	2011-02-07	Inhibition of secretion from non-neuronal cells
GB201100097D0	2011-01-05	Delivery vehicle
US2011158973A1	2010-12-16	Suppression of cancers